Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm. 2003 Jul 15;60(14):1447-58.E. Oren, E. R. Shaffer, and B.J. Guglielmo, "Impact of emerging technologies on medication errors and adverse drug events", American Journal of Health- ...
Subscribe to this journal Receive 12 digital issues and online access to articles 111,21 € per year only 9,27 € per issue Learn more Buy this article Purchase on SpringerLink Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during...
- Company 477 - Technology to embed Nitric Oxide (NO), part of the innate immune system, into polymer medical devices to make them antimicrobial without the issues of antibiotic resistance- Company 478 - Minimally invasive catheter-based system that safely, rapidly, and effectively removes thrombus...
drugs can also modulate the composition and function of gut microbiota, leading to changes in microbial metabolism and immune response. We also discuss the practical challenges, strategies, and opportunities in this field, emphasizing the critical need to develop an innovative approach to multi-omics,...
[6,48], offering a unique opportunity to address these multifaceted issues. Big Data techniques augmented by machine learning algorithms are particularly suited for addressing PD’s ‘high-dimensional’ complexity and therapeutic response. They can exploit data variability and heterogeneity to uncover ...
The aim of this review is to inform the reader of emerging issues and present new key highlights in the therapeutic development for IIH. Epidemiology IIH is considered a rare condition. Previously, the incidence within the general population was believed to be between 0.5 and 2 per 100,000 ...
(oncology knowledge base), and that only validated genomic alterations should be considered for daily practice.5 The availability and use of biomolecular technologies in routine clinical practice remains heterogeneous and multifactorial, both within and across countries. Economic issues, barriers to access...
Individuals with cardiovascular issues, high blood pressure, or hyperthyroidism should exercise caution. Interactions with Other Medications Clenbuterol may interact with certain medications, including beta-blockers, digoxin, and monoamine oxidase inhibitors (MAOIs). It’s essential to disclose all ...
Policy options for addressing issues related to hypertension and the shifting burden of disease in LICs face formidable implementation challenges due to strained health systems that are coping with a dual burden of infectious and non-communicable diseases, have restricted resources for NCD-related health...
This will become more of an issue moving forward, where a plethora of new systems will become relevant to providing care. Even initial movements towards supporting informal care processes suffer from the same issues: concerning a single standalone application or closed service, focusing on a ...